|本期目录/Table of Contents|

[1]赖宇星,苏津自.急性ST段抬高型心肌梗死患者短期预后的影响因素[J].慢性病学杂志,2019,20(12):1893-1896.
点击复制

急性ST段抬高型心肌梗死患者短期预后的影响因素

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
20
期数:
2019年12期
页码:
1893-1896
栏目:
专题报道
出版日期:
2019-12-28

文章信息/Info

Title:
-
作者:
赖宇星; 苏津自
福建医科大学附属第一医院心血管内科，福州 350005
Author(s):
-
关键词:
急性ST段抬高型心肌梗死; 心血管不良事件; 预后相关因素; 危险因素; 短期预后
Keywords:
-
分类号:
R544.1
DOI:
-
摘要:
目的 探讨接受早期再灌注治疗的急性ST段抬高型心肌梗死（STEMI）患者短期预后的影响因素。 方法 选取2014年6月至2018年12月福建医科大学附属第一医院连续接受急诊经皮冠状动脉介入治疗（PCI） 的347例早期再灌注治疗的STEMI患者资料，比较有无主要心血管不良事件（MACE）基线的差异。采用单因 素、多因素Logistic回归分析，建立MACE事件的危险评分，作ROC曲线检验模型的特异性和灵敏度评估。 结果 住院期间MACE事件的危险因素主要有高龄、女性、总缺血时间及手术时间延长、前降支梗死、射血分 数降低、心肌节段运动不良、肌酐、脑钠肽（pro-BNP）、肌酸激酶工酶（CKMB）、超敏C-反应蛋白（hs-CRP）、左心室收缩末期内径（LVDs）、二尖瓣环舒张早期血流比（E/e）及中性粒细胞淋巴细胞比值升高、淋巴 细胞异常、低肾小球滤过率（GFR）、室壁瘤等。其中年龄、手术时间、最高pro-BNP为其独立危险因素，以此 建立的MACE模型预测的敏感性和特异性较好，每增加1分，住院期间MACE事件发生率增加2.312倍。 结论 STEMI患者短期预后的影响因素众多，其中年龄、手术时间、最高pro-BNP为独立危险因素。
Abstract:
-

参考文献/References:

[1] Kristian T, Joseph S, Alpert AS,et al. Fourth universal definition of myocardial infarction (2018) [J]. J Am Coll Cardiol,2018,72(18):2256-2264. [2] Scholz KH, Maier SKG, Maier LS, et al. Impact oftreatment delay on mortality in ST- segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT- STEMI trial [J]. Euro Heart J,2018,39(13):1065-1074. [3] Cao B, Wang HP, Zhang C, et al. Remote ischemic postcon ditioning (RIPC) of the upper arm results in pro-tection from cardiac ischemia- reperfusion injury following primary percutaneous coronary intervention (PCI) for acute ST- segment elevation myocardial infarction (STEMI) [J]. Med Sci Monit,2018,19(24):1017-1026. [4] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急 性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2015,43(5):380-393. [5] Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group.2017 ESC Guidelines for the manage-ment of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the man-agement of acute myocardial infarction in patients present-ing with ST-segment elevation of the European Society of Cardiology (ESC) [J]. Euro Heart J,2018,26(9):417-421. [6] Xin W, Xiangna C, Lan C, et al. The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflam-mation in Patients with Acute ST-Segment Elevation Myo-cardial Infarction after PCI [J]. Med Inflam, 2015(1):1-6. [7] Kristian T, Joseph S, Alpert AS,et al. Fourth universal definition of myocardial infarction (2018) [J]. J Am Coll Cardiol,2018,72(18):2231-2244. [8] Chen W, Gao R, Liu L,et al. Summary of "China Car-diovascular Disease Report2017" [J]. Chinese J Circulation, 2018,33(1):235-243. [9] Tscharre M, Jager B, Farhan S,et al. Impact of time of admission on short- and long-term mortality in the Vien-na STEMI registry [J]. Int J Cardiol,2017(244):1-6. [10] Yamada T, Takahashi A, Mizuguchi Y,et al. Impact of shorter doorto-balloon time on prognosis of patients with STEMIsingle- center analysis with a large proportion of the patients treated within 30 min [J]. Cardiovasc Interv Ther,2018,34(2):97-104. [11] 中国医师协会急诊医师分会,中华医学会心血管病学分会,中华 医学会检验医学分会.急性冠脉综合征急诊快速诊疗指南[J].中 华危重症医学杂志(电子版),2016,9(2):73-80. [12] Roffi M, Patrono C, Collet JP,et al. 2015 ESC guide-lines for the management of acute coronary syndromes in patients presenting without persistent ST- segment eleva-tion: Task Force for the Management of Acute Coronary Syndrome in Patients Presenting without Persistent ST-segment Elevation of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2016,37(3):267-315. [13] O'connor RE, Alali AS, Brady WJ,et al. Part 9: acute coronary syndrome: 2015 American Heart Association Guidelines Update for cardiopulmonary Resuscitation and Emergency Cardiovascular Care [J]. Circul,2015,132(sup-pl2): S483-S500. [14] Turgay C, Balta S, Ozturk C,et al. Whole blood cell pa-rameters help us predict the prognosis in patients with acute ST segment elevation myocardial infarction: Myth or reality [J]. Cardiol J, 2016,23(3):357-358. [15] Azab B, Shan N, Akerman M,et al. Value of plate let/ lymphocyte ratio as a predictor of all cause mortality after non-ST-elevation myocardial infarction [J]. ThrombThrom-bolysis,2012,34(3): 326-334. [16] 李少辉,王海昌,张英梅,等.血小板与淋巴细胞比率对急性ST段 抬高型心肌梗死患者PCI术后无复流的预测价值[J].现代生物医 学进展,2016,16(17):729-731.

备注/Memo

备注/Memo:
作者简介：赖宇星，硕士，住院医师，研究方向：心肌梗 死治疗 通信作者：苏津自，E-mail:sujinzi2014@163.com
更新日期/Last Update: 2019-12-28